Chapter 107. Transfusion Biology and Therapy (Part 6)

Immune-Mediated ReactionsAcute Hemolytic Transfusion ReactionsImmune-mediated hemolysis occurs when the recipient has preformed antibodies that lyse donor erythrocytes. The ABO isoagglutinins are responsible for the majority of these reactions, although alloantibodies directed against other RBC antigens, i.e., Rh, Kell, and Duffy, may result in hemolysis.Acute hemolytic reactions may present with hypotension, tachypnea, tachycardia, fever, chills, hemoglobinemia, hemoglobinuria, chest and/or flank pain, and discomfort at the infusion site. Monitoring the patients vital signs beforeand during the transfusion is important to identify reactions promptly. When acute hemolysis is suspected, the transfusion must be stopped immediately, intravenous access maintained, and the reaction reported...
Nội dung trích xuất từ tài liệu:
Chapter 107. Transfusion Biology and Therapy (Part 6) Chapter 107. Transfusion Biology and Therapy (Part 6) Immune-Mediated Reactions Acute Hemolytic Transfusion Reactions Immune-mediated hemolysis occurs when the recipient has preformedantibodies that lyse donor erythrocytes. The ABO isoagglutinins are responsiblefor the majority of these reactions, although alloantibodies directed against otherRBC antigens, i.e., Rh, Kell, and Duffy, may result in hemolysis. Acute hemolytic reactions may present with hypotension, tachypnea,tachycardia, fever, chills, hemoglobinemia, hemoglobinuria, chest and/or flankpain, and discomfort at the infusion site. Monitoring the patients vital signs beforeand during the transfusion is important to identify reactions promptly. When acutehemolysis is suspected, the transfusion must be stopped immediately, intravenousaccess maintained, and the reaction reported to the blood bank. A correctly labeledposttransfusion blood sample and any untransfused blood should be sent to theblood bank for analysis. The laboratory evaluation for hemolysis includes themeasurement of serum haptoglobin, lactate dehydrogenase (LDH), and indirectbilirubin levels. The immune complexes that result in RBC lysis can cause renaldysfunction and failure. Diuresis should be induced with intravenous fluids andfurosemide or mannitol. Tissue factor released from the lysed erythrocytes mayinitiate DIC. Coagulation studies including prothrombin time (PT), activatedpartial thromboplastin time (aPTT), fibrinogen, and platelet count should bemonitored in patients with hemolytic reactions. Errors at the patients bedside, such as mislabeling the sample or transfusingthe wrong patient, are responsible for the majority of these reactions. The bloodbank investigation of these reactions includes examination of the pre- andposttransfusion samples for hemolysis and repeat typing of the patient samples;direct antiglobulin test (DAT), sometimes called the direct Coombs test, of theposttransfusion sample; repeating the cross-matching of the blood component; andchecking all clerical records for errors. DAT detects the presence of antibody orcomplement bound to RBCs in vivo. Delayed Hemolytic and Serologic Transfusion Reactions Delayed hemolytic transfusion reactions (DHTRs) are not completelypreventable. These reactions occur in patients previously sensitized to RBCalloantigens who have a negative alloantibody screen due to low antibody levels.When the patient is transfused with antigen-positive blood, an anamnesticresponse results in the early production of alloantibody that binds donor RBCs.The alloantibody is detectable 1–2 weeks following the transfusion, and theposttransfusion DAT may become positive due to circulating donor RBCs coatedwith antibody or complement. The transfused, alloantibody-coated erythrocytesare cleared by the reticuloendothelial system. These reactions are detected mostcommonly in the blood bank when a subsequent patient sample reveals a positivealloantibody screen or a new alloantibody in a recently transfused recipient. No specific therapy is usually required, although additional RBCtransfusions may be necessary. Delayed serologic transfusion reactions are similarto DHTR, as the DAT is positive and alloantibody is detected; however, RBCclearance is not increased. Febrile Nonhemolytic Transfusion Reaction The most frequent reaction associated with the transfusion of cellular bloodcomponents is a febrile nonhemolytic transfusion reaction (FNHTR). Thesereactions are characterized by chills and rigors and a ≥1°C rise in temperature.FNHTR is diagnosed when other causes of fever in the transfused patient are ruledout. Antibodies directed against donor leukocyte and HLA antigens may mediatethese reactions; thus, multiply transfused patients and multiparous women are feltto be at increased risk. Although antibodies may be demonstrated in the recipientsserum, investigation is not routinely done because of the mild nature of mostFNHTR. The use of leukocyte-reduced blood products may prevent or delaysensitization to leukocyte antigens and thereby reduce the incidence of thesefebrile episodes. Cytokines released from cells within stored blood componentsmay mediate FNHTR; thus, leukoreduction before storage may prevent thesereactions. The incidence and severity of these reactions can be decreased inpatients with recurrent reactions by premedicating with acetaminophen or otherantipyretic agents. Allergic Reactions Urticarial reactions are related to plasma proteins found in transfusedcomponents. Mild reactions may be treated symptomatically by temporarilystopping the transfusion and admin ...